Evaluating drugs after their approval for clinical use.
Ray
W A
WA
Department of Preventive Medicine, Vanderbilt University School of Medicine, Nashville, TN 37232.
Griffin
M R
MR
Avorn
J
J
D016907:Adverse Drug Reaction Reporting Systems / Q000592:standards*; D000368:Aged; D011307:Drug Prescriptions / Q000592:standards*; D004358:Drug Therapy / Q000592:standards*; D005069:Evaluation Studies as Topic; D006801:Humans; D011358:Product Surveillance, Postmarketing; D014481:United States; D014486:United States Food and Drug Administration